ProQR Therapeutics (PRQR) Invested Capital (2021 - 2024)
Historic Invested Capital for ProQR Therapeutics (PRQR) over the last 4 years, with Q4 2024 value amounting to $108.1 million.
- ProQR Therapeutics' Invested Capital rose 7684.27% to $108.1 million in Q4 2024 from the same period last year, while for Sep 2025 it was -$0.0, marking a year-over-year decrease of 10000.0%. This contributed to the annual value of $109.5 million for FY2024, which is 7816.03% up from last year.
- As of Q4 2024, ProQR Therapeutics' Invested Capital stood at $108.1 million, which was up 7684.27% from $61.1 million recorded in Q4 2023.
- ProQR Therapeutics' 5-year Invested Capital high stood at $175.8 million for Q4 2021, and its period low was $19910.1 during Q1 2021.
- Its 4-year average for Invested Capital is $43.8 million, with a median of $20.7 million in 2021.
- Its Invested Capital has fluctuated over the past 5 years, first soared by 21618109.17% in 2022, then crashed by 9034.26% in 2023.
- ProQR Therapeutics' Invested Capital (Quarter) stood at $175.8 million in 2021, then tumbled by 52.47% to $83.5 million in 2022, then decreased by 26.8% to $61.1 million in 2023, then skyrocketed by 76.84% to $108.1 million in 2024.
- Its last three reported values are $108.1 million in Q4 2024, $61.1 million for Q4 2023, and $3.1 million during Q3 2023.